🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to constitute the French largest Aggressive fi...
Status
Active Not Recruiting
Location
Institut de Cancérologie de l'Ouest - Paul Papin
Start Date
2016-03-22
Trial ID
NCT02867033
Although more than 50% of survivors of critical illness experience one or m...
Status
Completed
Location
Vanderbilt University Medical Center
Start Date
2019-11-01
Trial ID
NCT03926533
Treatments Being Tested
The LAMBDA 002 registry study is an observational, longitudinal, multi-cent...
Status
Active Not Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2022-11-04
Trial ID
NCT05170425
Treatments Being Tested
Lupus nephritis (LN) develops in 30-60% of systemic lupus erythematosus (SL...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-01
Trial ID
NCT07505576
The purpose of this study is to evaluate the SpO2 accuracy and performance ...
Status
Completed
Location
Multiple Locations
Start Date
2016-06
Trial ID
NCT02842476
Treatments Being Tested
A prospective, mono-center, interventional study evaluating the effect of o...
Status
Completed
Location
CHU Rennes
Start Date
2019-06-11
Trial ID
NCT03942432
Treatments Being Tested
This phase I/II clinical trial is studying the side effects and best dose o...
Status
Terminated
Location
Lucile Packard Children's Hospital Stanford University
Start Date
2010-03
Trial ID
NCT01088763
Imatinib mesylate may stop the growth of tumor cells by blocking the enzyme...
Status
Terminated
Location
Cancer and Leukemia Group B
Start Date
2002-06
Trial ID
NCT00042952
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of melphalan w...
Status
Completed
Location
University of Minnesota/Masonic Cancer Center
Start Date
2005-09-15
Trial ID
NCT00303849
The goal of this study is to: 1. Assess the usability of the SynPhNe devic...
Status
Recruiting
Location
Spaulding Rehabilitation Hospital
Start Date
2025-02-26
Trial ID
NCT02896348
Treatments Being Tested